HDAC inhibitors can arrest the lymphoma cell cycle and inhibit cell proliferation by dysregulating the G1-S and S-G2-M checkpoints in the cell cycle [45], inducing lymphoma cell differentiation and promoting the apoptosis of lymphoma cells in PTCL [46]. Here, HDAC9 is linked to lymphoma.